Bulk orders for COVID-19 tests are on the rise as companies brace for a winter surge.
Let's talk about two leaders in their markets and a well-diversified healthcare company with a track record of success. Vertex Pharmaceuticals (NASDAQ: VRTX) has been generating returns for investors for quite a while. Vertex is the global market leader in the treatment of cystic fibrosis (CF).
In the latest trading session, Abbott (ABT) closed at $99.84, marking a -0.83% move from the previous day.